Envoy Therapeutics Inc - CA San Diego, San Diego 92121

Envoy Therapeutics Inc entered the industry of Biological Research in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Bradley A Margus by calling (503) 784-2159 during business hours. You can also write to the business’ Single Location at 10410 Science Center Drive, San Diego, California CA 92121. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Envoy Therapeutics Inc
Representative: Bradley A Margus
Place of Business: 10410 Science Center Drive, San Diego, CA 92121
Contact Number: (503) 784-2159
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2008
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Envoy Therapeutics Inc is a company operating from San Diego, California providing professional Biological Research and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.

With a current employee count of 1 to 4, Envoy Therapeutics Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Bradley A Margus at (503) 784-2159 for related queries, or to locate its Single Location using the coordinates 32.890869,-117.232106.

The Single Location can also be found at the street address 10410 Science Center Drive in San Diego, California 92121 and can be engaged online through the company website at , the company Twitter , and Facebook page .